EdgeMarketInstruments › VERU

VERU — VERU INC.

US Healthcare Pharma & biotech equity mkt cap 45.0M
2.64 +2.33% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 2.09 · high 4.43

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day+2.33%
1 week-3.30%
1 month+14.29%
3 months+18.92%
6 months+5.60%
Year to date+16.30%
1 year-25.21%
3 years-75.56%
5 years-96.51%

Technicals

RSI 1467.6
vs 50-day avg-0.66%
vs 200-day avg+6.28%
Volatility 1y110.8%
Max drawdown 1y-52.82%
Avg volume 30d267.6K
Daily bars held2,674
History from2016-01-04

Measured signals that fired on VERU

datesignal measured base rate
2026-04-01Short volume far above its own normal
short
-0.76% over 21 days · t = -2.79 · n = 5,897
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-08-13BARNETTE K GARY
Chief Scientific Officer
Open-market purchase1.8K2.694.8K
2025-02-19Rankowitz Michael L
Director
Open-market purchase54.7K0.5831.7K
2025-02-18Rankowitz Michael L
Director
Open-market purchase95.3K0.5552.4K
2024-05-24STEINER MITCHELL SHUSTER
President and CEO
Open-market sale63.4K1.2378.0K
2024-05-24BARNETTE K GARY
Chief Scientific Officer
Open-market purchase5.0K1.346.7K
2024-05-24FISCH HARRY
Chief Corporate Officer
Open-market purchase4.0K1.255.0K
2024-05-23STEINER MITCHELL SHUSTER
President and CEO
Open-market sale3001.35405
2024-05-22STEINER MITCHELL SHUSTER
President and CEO
Open-market sale6.5K1.399.0K
2024-05-17STEINER MITCHELL SHUSTER
President and CEO
Open-market sale28.1K1.3237.0K
2024-05-16STEINER MITCHELL SHUSTER
President and CEO
Open-market sale59.8K1.4184.3K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
Alyeska Investment Group, L.P.2.2M1.0M
VANGUARD CAPITAL MANAGEMENT LLC1.2M539.4K
OPPENHEIMER & CO INC433.8K196.3K
GEODE CAPITAL MANAGEMENT, LLC408.1K184.6K
Summit Financial, LLC335.4K151.8K
MILLENNIUM MANAGEMENT LLC332.4K150.4K
Ikarian Capital, LLC295.1K133.5K
BlackRock, Inc.252.3K114.2K
VANGUARD FIDUCIARY TRUST CO178.2K80.7K
CHOREO, LLC166.3K75.3K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
42026-08-172026-08-13on EDGAR ↗
10-Q2026-08-102026-06-30on EDGAR ↗
8-K2026-08-102026-08-10on EDGAR ↗
8-K2026-07-022026-07-02on EDGAR ↗
424B52026-07-02on EDGAR ↗
8-K2026-06-042026-06-02on EDGAR ↗
S-82026-05-13on EDGAR ↗
10-Q2026-05-132026-03-31on EDGAR ↗

Short selling

Avg short volume, 90d40.2% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about VERU

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open VERU in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →